Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.12073
Abstract: This cohort study examines neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.1) after the second and third doses of the BNT162b2 mRNA vaccine among Danish adults. read more here.
Keywords: omicron variant; neutralizing antibodies; cov omicron; second third ... See more keywords
Seroprevalence of SARS-CoV-2 Antibodies Among Blood Donors in Malaysia During the Pre-Vaccination Period
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Infectious Diseases"
DOI: 10.1016/j.ijid.2021.12.080
Abstract: Purpose We aimed to investigate the prevalence of antibodies against SARS-CoV-2 virus among blood donors in Klang Valley; a cohort that represent healthy individuals in a city which recorded a high number of COVID-19 infections… read more here.
Keywords: among blood; sars cov; antibodies sars; blood donors ... See more keywords
Concordance between two rapid diagnostic tests for the detection of antibodies against SARS-CoV-2
Sign Up to like & getrecommendations! Published in 2020 at "Semergen"
DOI: 10.1016/j.semerg.2020.06.009
Abstract: Objective To assess the agreement between two rapid detection tests (RDT) for antibodies against SARS-CoV-2 infection. Materials and methods This was a cross-sectional study that used a random sample of non-hospitalized patients from the primary… read more here.
Keywords: detection; antibodies sars; two rapid; sars cov ... See more keywords
Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil
Sign Up to like & getrecommendations! Published in 2020 at "Nature Medicine"
DOI: 10.1038/s41591-020-0992-3
Abstract: Population-based data on COVID-19 are urgently needed. We report on three rounds of probability sample household surveys in the state of Rio Grande do Sul (Brazil), carried out in nine large municipalities using the Wondfo… read more here.
Keywords: state; antibodies sars; population based; sars cov ... See more keywords
Neutralizing antibodies against the SARS-CoV-2 Omicron variant following homologous and heterologous CoronaVac or BNT162b2 vaccination.
Sign Up to like & getrecommendations! Published in 2022 at "Nature medicine"
DOI: 10.1038/s41591-022-01704-7
Abstract: The Omicron variant is rapidly becoming the dominant SARS-CoV-2 virus circulating globally. It is important to define reductions in virus neutralizing activity in serum of convalescent or vaccinated individuals to understand potential loss of protection… read more here.
Keywords: sars cov; omicron variant; antibodies sars; neutralizing antibodies ... See more keywords
Antibodies to SARS-CoV-2 and risk of past or future sick leave
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-84356-w
Abstract: The extent that antibodies to SARS-CoV-2 may protect against future virus-associated disease is unknown. We invited all employees (n = 15,300) at work at the Karolinska University Hospital, Stockholm, Sweden to participate in a study examining SARS-Cov-2… read more here.
Keywords: risk; antibodies sars; disease; sick leave ... See more keywords
High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
Sign Up to like & getrecommendations! Published in 2021 at "Scientific Reports"
DOI: 10.1038/s41598-021-92775-y
Abstract: Since the beginning of the pandemic of COVID-19, there has been a widespread assumption that most infected persons are asymptomatic. Using data from the recent wave of the EPICOVID19 study, a nationwide household-based survey including… read more here.
Keywords: changes smell; antibodies sars; subjects antibodies; high prevalence ... See more keywords
Guillain‐Barré syndrome in a patient with antibodies against SARS‐COV‐2
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Neurology"
DOI: 10.1111/ene.14388
Abstract: ABSTRACT There are now several reports on neurologic features of SARS‐CoV‐2 infection.1 2 In a recent study of 214 patients with COVID‐19, 78 (36.4%) patients had neurological manifestations, including headache, dizziness, acute cerebrovascular diseases, and… read more here.
Keywords: antibodies sars; syndrome patient; guillain barr; patient antibodies ... See more keywords
Evidence of antibodies against SARS‐CoV‐2 in wild mustelids from Brittany (France)
Sign Up to like & getrecommendations! Published in 2022 at "Transboundary and Emerging Diseases"
DOI: 10.1111/tbed.14663
Abstract: In the French region of Brittany, mainly in the department of the Côtes d’Armor, during the first semester of 2021, seropositivity for SARS-CoV-2 was detected in five wild mustelids out of 32 animals tested. Anti-SARS-CoV-2… read more here.
Keywords: brittany; evidence antibodies; cov wild; sars cov ... See more keywords
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-054688
Abstract: Introduction National SARS-CoV-2 seroprevalence data provide essential information about population exposure to the virus and help predict the future course of the epidemic. Early cohort studies have suggested declines in levels of antibodies in individuals… read more here.
Keywords: among primary; cohort; antibodies sars; study ... See more keywords
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2022-065897
Abstract: Objectives To estimate the prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers (PHCPs). Design Prospective cohort study with 12 months of follow-up. Setting Primary care in Belgium. Participants Any general practitioner… read more here.
Keywords: longevity antibodies; vaccination; incidence; antibodies sars ... See more keywords